Why COVID-19 patients who could most benefit from Paxlovid still aren’t getting it
American Nurse
MARCH 13, 2024
A recent JAMA Network study found that sick people 85 and older were less likely than younger Medicare patients to get covid therapies like Paxlovid. Shrunken confidence in government health programs is one reason the drug isn’t reaching those who need it. Nursing home patients, who account for around 1 in 6 U.S.
111 
Let's personalize your content